ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $52,000 | -97.6% | 14,979 | -97.6% | 0.01% | -98.3% |
| Q1 2021 | $2,171,000 | +135.7% | 634,728 | +1223.9% | 0.42% | +138.4% |
| Q4 2020 | $921,000 | -12.4% | 47,945 | -38.8% | 0.18% | +12.7% |
| Q3 2020 | $1,051,000 | -38.7% | 78,278 | +93.3% | 0.16% | -54.4% |
| Q2 2020 | $1,715,000 | +26.8% | 40,500 | -17.3% | 0.34% | -38.8% |
| Q1 2020 | $1,353,000 | -22.6% | 48,988 | -9.0% | 0.56% | +16.1% |
| Q4 2019 | $1,747,000 | -27.7% | 53,839 | -42.0% | 0.48% | -62.8% |
| Q3 2019 | $2,417,000 | -50.5% | 92,854 | -30.2% | 1.30% | -78.8% |
| Q2 2019 | $4,884,000 | -5.5% | 133,105 | -43.1% | 6.14% | +147.3% |
| Q1 2019 | $5,168,000 | -64.0% | 233,727 | -54.9% | 2.48% | -21.4% |
| Q4 2018 | $14,355,000 | +41.2% | 518,125 | -1.1% | 3.16% | +142.7% |
| Q3 2018 | $10,164,000 | -20.4% | 523,653 | -9.5% | 1.30% | -34.1% |
| Q2 2018 | $12,775,000 | -58.9% | 578,599 | -60.6% | 1.97% | +6.3% |
| Q1 2018 | $31,104,000 | +50.7% | 1,468,544 | +77.9% | 1.86% | -1.2% |
| Q4 2017 | $20,636,000 | – | 825,451 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |